Cardiovascular disease in Cushing's syndrome: Heart versus vasculature

Neuroendocrinology

Volumn 92, Issue SUPPL. 1, 2010, Pages 50-54

  De Leo, Monica ^a   Pivonello, Rosario ^a   Auriemma, Renata S ^a   Cozzolino, Alessia ^a   Vitale, Pasquale ^a   Simeoli, Chiara ^a   De Martino, Maria Cristina ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Atherosclerosis; Cardiac abnormalities; Cardiac hypertrophy; Cardiovascular disease; Cardiovascular risk; Coagulopathy; Cushing's disease; Cushing's syndrome; Hypertension; Metabolic syndrome; Vascular abnormalities

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; CORRELATION ANALYSIS; CUSHING DISEASE; CUSHING SYNDROME; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HEART HYPERTROPHY; HUMAN; HYPERCORTISOLISM; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

CARDIOVASCULAR DISEASES; CUSHING SYNDROME; HEART; HUMANS; RISK;

EID: 77956526190     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318566     Document Type: Conference Paper

References (20)

1. Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A: Cushing's syndrome. Endocrinol Metab Clin Nort h Am 2008; 37: 135-149.
2. Exabe J, Vazquez JA: Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994; 4: 479-484.
3. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jør-gensen J, Kosteljanetz M, Kristensen L, Laur-berg P, Schmidt K, Weeke J: Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001; 86:117-123.
4. Pivonello R, De Martino MC, De Leo M, Tauchmanovà L, Faggiano A, Lombardi G, Colao A: Cushing's syndrome: aftermath of the cure. Arq Bras Endocrinol Metab 2007; 51: 1381-1391.
5. Pivonello R, Faggiano A, Lombardi G, Colao A: The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocri-nol Metab Clin Nor th Am 2005; 34: 327-339.
6. Cameron AJ, Shaw JE, Zimmet PZ: The metabolic syndrome: prevalence in worldwide population. Endocrinol Metab Clin North Am 2004; 33: 351-375.
7. Faggiano A, Pivonello R, Spiezia S, De Mar-tino MC, Filippella M, Di Somma C, Lom-bardi G, Colao A: Cardiovascular risk factors and common carotid artery calibre and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003; 88: 2527-2533.
8. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G: Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999; 84:2664-2672.
9. Albiger N, Testa RM, Almoto B, Ferrari M, Bilora F, Petrobelli F, Pagnan A, Mantero F, Scaroni C: Patients with Cushing's syndrome have increased intima-media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors. Horm Metab Res 2006; 38:405-410.
10. Baykan M, Erem C, Gedikli O, Hacihasano-glu A, Erdogan T, Kocak M, Kaplan S, Kirí A, Orem C, Celi k S: Impai rment of f low-mediated vasodilatation of brachial artery in patients with Cushing's syndrome 2007; 25: 182-19 0.
11. Ermetici F, Malavazos AE, Corbetta S, Eller-Vainicher C, Cannavò S, Corsi MM, Ambrosi B: Soluble adhesion molecule levels in patients with Cushing's syndrome before and after cure. J Endocrinol Invest 2008; 31: 389-392.
12. Kristo C, Ueland T, Godang K, Aukrust P, Bollerslev J: Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome. J Endocrinol Invest 2008; 31:400-405.
13. Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, Patrassi GM, Girolami A: Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 2002; 87:3662-3666.
14. Terzolo M, Allasino B, Bosio S, Brusa E, Daf-fara F, Ventura M, Aroasio E, Sacchetto G, Reimondo G, Angeli A, Camaschella C: Hy-perhomocysteinemia in patients with Cush-ing's syndrome. J Clin Endocrinol Metab 2004; 89: 3745-3751.
15. Faggiano A, Melis D, Alfieri R, De Martino M, Filippella M, Milone F, Lombardi G, Co-lao A, Pivonello R: Sulfur amino acids in Cushing's disease: insight homocysteine and taurine levels in patients with active and cured disease. J Clin Endocrinol Metab 2005; 90:6616-6622.
16. Magiakou MA, Smyrnaki P, Chrousos GP: Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab 2006; 20: 467-482.
17. Pecori Giraldi F, Toja PM, De Martin M, Ma-ronati A, Scacchi M, Omboni S, Cavagnini F, Parati G: Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Horm Metab Res 2007; 39:908-914.
18. Muiesan ML, Lupia M, Salvetti M, Grigolet-to C, Sonino N, Boscaro M, Rosei EA, Man-tero F, Fallo F: Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 2003; 41:2275-2279.
19. Pereira AM, Delgado V, Romijn JA, Smit JW, Bax JJ, Feelders RA: Cardiac dysfunction is reserved upon successful treatment of Cush-ing's syndrome. Eur J Endocrinol 2010; 162: 331-340.
20. Fallo F, Maffei P, Dalla Pozza A, Carli M, Della Mea P, Lupia M, Rabbia F, Sonino N: Cardiovascular autonomic function in Cushing's syndrome. J Endocrinol Invest 2009; 32:41-45.